From July 3, 2023 to September 30, 2023, the company has repurchased 731,500 shares, representing 0.08% for CNY 20.1 million. With this, the company has completed the repurchase of 731,500 shares, representing 0.08% for CNY 20.1 million under the buyback announced on July 4, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.14 CNY | +2.34% | -2.70% | +30.89% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.89% | 5.24B | |
+29.68% | 681B | |
+21.40% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+13.62% | 235B | |
+4.56% | 199B | |
-12.43% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- 600566 Stock
- News Hubei Jumpcan Pharmaceutical Co., Ltd.
- Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.